Assailant of Opposition Leader Lee Jae-myung Indicted on Multiple Charges in BusanSK Biopharmaceuticals Reports Annual Net Loss for 2023

BUSAN—The individual who attacked Lee Jae-myung, the leader of the main opposition Democratic Party, with a knife earlier in the month, has been formally charged with attempted murder and violation of election law.

According to Yonhap News Agency, which occurred during Lee's visit to Busan on January 2, saw the 67-year-old assailant, identified only by his surname Kim, apprehend Lee and stab him in the neck. Kim has since stated that his actions were driven by a desire to prevent Lee from assuming the presidency.

Following an extensive investigation that lasted several weeks, the prosecution announced on Monday the indictment of Kim on charges of attempted murder and election law violation. The allegations suggest that Kim aimed to disrupt the electoral process and influence the outcome of April's general election through violence, thereby undermining the principles of electoral freedom.

In addition to Kim's indictment, the authorities have also charged a 75-year-old man, whose name has been withheld, with aiding in the attempted murder and violating the Public Official Election Act. This development comes after the prosecution investigated a total of 114 individuals connected to the case, ultimately concluding that there were no further accomplices or masterminds behind the attack on Lee Jae-myung.

SEOUL — SK Biopharmaceuticals Co. disclosed its financial results for the year 2023 on Monday, revealing a net loss of 36.3 billion won ($27.2 million), continuing its streak of operating in the red compared to the previous year. The company's regulatory filing highlighted that, despite the net loss, there was a significant reduction in its operating loss to 37.1 billion won from 131.1 billion won a year earlier. Moreover, the company witnessed a 44.2 percent increase in revenue, reaching 354.9 billion won.

According to Yonhap News Agency, the decrease in operating loss and the substantial rise in revenue reflect a partial recovery in its business operations, although challenges remain in achieving full profitability.

scroll to top